Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity
Year: 2020
Type: article
Abstract: Central to anti-tumor immunity are dendritic cells (DCs), which stimulate long-lived protective T cell responses. Recent studies have demonstrated that DCs can achieve a state of hyperactivation, which is associated with inflammasome activities within living cells. Herein, we report that hyperactive DCs have an enhanced ability to migrate to draining lymph nodes and stimulate potent cytotoxic T lymphocyte (CTL) responses. This enhanced migratory activity is dependent on the chemokine receptor CCR7 and is associated with a unique transcriptional program that is not observed in conventionally activated or pyroptotic DCs. We show that hyperactivating stimuli are uniquely capable of inducing durable CTL-mediated anti-tumor immunity against tumors that are sensitive or resistant to PD-1 inhibition. These protective responses are intrinsic to the cDC1 subset of DCs, depend on the inflammasome-dependent cytokine IL-1β, and enable tumor lysates to serve as immunogens. If these activities are verified in humans, hyperactive DCs may impact immunotherapy.
Source: Cell Reports
Institutions: Boston Children's Hospital, Harvard University, University of Naples Federico II, Massachusetts General Hospital, Broad Institute, Ragon Institute of MGH, MIT and Harvard, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Washington University in St. Louis
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,200
Funders: Burroughs Wellcome Fund, Pew Charitable Trusts, Alfred P. Sloan Foundation, Merck, Massachusetts General Hospital, Harvard University, National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1440100979, G1451570152, Center for Cell Circuits, Characterization of the myddosome, a protein complex that controls TLR signaling, The Role of Innate Immune Cell Trafficking in Th2 Differentiation, Quantitative and functional characterization of therapeutic resistance in cancer, Initiation and Regulation of Antiviral Innate Immunity, G588084914, Defining regulators of immunity to acute infection using CRISPR screens, G750701822, "Bottom - Up" Profiling of Interacting Cellular Systems, G8542622280, Initiation and Regulation of Antiviral Innate Immunity, Type III interferon Control of Mucosal Immunity, Defining the pathways activated by Toll-like Receptors to stimulate immunity, Molecular Basis of Viral Infectivity, Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital, Integrated Epithelial and Muscosal Biology, Innate control of the inflammatory process during fungal infections
OpenAlex ID: W3102973844
